Publications by authors named "Koca Sinan"

Claim this Profile
N
Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients.
İrem Peker Eyüboğlu, Sinan Koca, Betül Çelik, Gökçe Güllü Amuran, M Ümit Uğurlu

Int J Breast Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between plasma ccfDNA, mtDNA changes, CTCs, and epithelial-mesenchymal transition in breast cancer patients undergoing NACT.
Betül Çelik, İrem Peker Eyüboğlu, Sinan Koca, M Ümit Uğurlu, Özkan Alan

Turk J Med Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study.
Elvina Almuradova, Mustafa Seyyar, Hacı Arak, Fatih Tamer, Umut Kefeli, Sinan Koca

Int J Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological state and predictors of psychiatric morbidity in COVID-19 patients six weeks after discharge.
Esra Koca, Murat Yıldırım, Lütfiye Söğütlü, Ekmel Geçer, Ülkü Tankut Yıldırım, Sinan Koca

Arch Psychiatr Nurs· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Ahmet Bilici, Sinan Koca, Mustafa Karaagac, Sabin Goktas Aydin, Emrah Eraslan

J Cancer Res Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.
Cihan Erol, Mehmet Ali Nahit Sendur, Irem Bilgetekin, Duygu Bayir Garbioglu, Jamshid Hamdard, Sinan Koca

J Cancer Res Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological impacts of COVID-19 pandemic in cancer patients on active treatment.
Sinan Koca, Esra Koca, Ilker N Okten, Fatma Fc Orengül, Akın Oztürk

Heliyon· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
Bülent Demirelli, Nalan Akgül Babacan, Özlem Ercelep, Mehmet Akif Öztürk, Serap Kaya, Sinan Koca

Nutr Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study.
Burak Bilgin, Mehmet Ali Nahit Sendur, Sebnem Yucel, Emir Celik, Deniz Tataroglu Ozyukseler, Sinan Koca

J Cancer Res Clin Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer.
Ayşe Demirci, Cemil Bilir, Burcu Gülbağcı, İlhan Hacıbekiroğlu, İbrahim V Bayoğlu, Sinan Koca

Sci Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastases.
Zeynep Oruç, M Ali Kaplan, Mustafa Karaağaç, Neslihan Özyurt, Ali Murat Tatlı, Sinan Koca

Future Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study.
Sinan Koca, Mehmet Beşiroğlu, Melike Özçelik, Mustafa Karaca, Mehmet Bilici

J Oncol Pharm Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early PSA response to antiandrogen therapy in metastatic castration-resistant prostate carcinoma patients: A predictive marker for progression-free survival?
Demir Atakan, Alan Ozkan, Mert Aslihan Guve, Koca Sinan

J BUON· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
Zeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli, Nilgun Yildirim Sari, Ersin Ozaslan, Sinan Koca

J BUON· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?
Ozkan Alan, Tugba Akin Telli, Bilge Aktas, Sinan Koca, Ilker Nihat Ökten

World J Surg Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy.
Mustafa Akkiprik, Sinan Koca, M Ümit Uğurlu, Rüçhan Ekren, İrem Peker Eyüboğlu

Clin Breast Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
Ozkan Alan, Okan Kuzhan, Sinan Koca, Tugba Akin Telli, Tugba Basoglu

J Oncol Pharm Pract· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
Zeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli, Nilgun Yildirim Sari, Ersin Ozaslan, Sinan Koca

J BUON· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy.
Nazim Demircan, Faysal Dane, Mehmet Akif Ozturk, Nalan Akgul Babacan, Mehmet Besiroglu, Sinan Koca

J BUON· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer.
Serap Kaya, Bilge Aktas, Eda Tanrikulu Sismek, Mehmet Akif Ozturk, Fuat Dede, Sinan Koca

J BUON· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less.
Ersin Özaslan, Halit Karaca, Sinan Koca, Alper Sevinç, Bekir Hacioğlu

Anticancer Drugs· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology.
Ozlem Ercelep, Turkan Ozturk Topcu, Ibrahim Vedat Bayoglu, Ahmet Siyar Ekinci, Sinan Koca

Tumour Biol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Another adverse effect of vemurafenib: Gingival hyperplasia.
Andac Salman, Burak Tekin, Sinan Koca, Nalan Akgul Babacan, Perran Fulden Yumuk

J Dermatol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology.
Melike Ozcelik, Mesut Seker, Emrah Eraslan, Sinan Koca, Dogan Yazilitas

Tumour Biol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged coagulopathy related to coumarin rodenticide in a young patient: superwarfarin poisoning.
Servet Altay, Huseyin Altug Cakmak, Gulsah Cemiloglu Boz, Sinan Koca, Yalcin Velibey

Cardiovasc J Afr· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis